Clinical Trial Update: A Study to Determine the Safety, Tolerability, and Effects of GSK2374697 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, and pharmacological effects of GSK2374697 in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GSK2374697

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED